CIK 0001783036
- Non-accelerated filer
- Emerging growth company
NewcelX Ltd.
Sign in to watch- Ticker
- NCEL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Other
- Phone
- +41 416188000
- Business address
- THE CIRCLE 6, 8058, ZURICH, Switzerland
- Former names
- NLS Pharmaceutics Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-27 | Samuel Olivier Director | Purchase | +81,818 | $2.75 | $225K | 81,818 |
| 2026-04-27 | Samuel Olivier Director | Purchase · Warrant (right to buy) | +114,545 | 114,545 | ||
| 2026-04-27 | Revel Michel CSO and Director | Purchase | +54,545 | $2.75 | $150K | 957,530 |
| 2026-04-27 | Revel Michel CSO and Director | Purchase · Warrant (right to buy) | +76,363 | 76,363 |
Page 1 of 1 · 4 trades